Blood-Based Diagnostic Assay from Biodesix Measures Immunotherapy Biomarker PD-L1 – Yahoo Finance
Yahoo Finance |
Blood-Based Diagnostic Assay from Biodesix Measures Immunotherapy Biomarker PD-L1
Yahoo Finance Dr. Michael Pritchett: "Understanding PD-L1 status is a central question in immuno-oncology." (Photo: Business Wire) Multimedia Gallery URL. More. BOULDER, Colo.–(BUSINESS WIRE)–. New data from Biodesix® evaluating an assay in development … |
